Lawton Alison Frances 4
4 · Magenta Therapeutics, Inc. · Filed Jun 30, 2022
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-28+20,000→ 20,000 totalExercise: $1.21Exp: 2032-06-27→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in full upon the earlier to occur of (a) June 28, 2023 or (b) the next annual meeting of the Issuer's stockholders.